No Data
No Data
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
HK stock anomaly | microport series rose in early trading, rumored that the major shareholder Okada is considering selling microport medical shares.
Microport shares rose in early trading, as of the time of publication, Siasun Robot&Automation-B (02252) rose by 7.77%, closing at 9.85 Hong Kong dollars; Microport (00853) rose by 6.41%, closing at 6.81 Hong Kong dollars.
Minimally Invasive Brain Science (02172): Short-term performance growth relies on centralized procurement, while long-term prospects depend on internationalization capabilities.
In the first half of the year, the only profitable company in the Hong Kong stock market is the MicroPort Group. The short-term performance growth of MicroPort NeuroTech relies on group procurement, while its long-term prospect lies in internationalization capabilities ~
HK Stock Special | Microport-related stocks collectively declined. Microport recently sold its properties to alleviate debt pressure.
Microport collectively fell, as of the publication, Microport Robot-B (02252) fell by 6.61%, to 10.46 Hong Kong dollars; Microport Medical (00853) fell by 6.17%, to 7.3 Hong Kong dollars; Microport Neurology (02172) fell by 3.85%, to 9.75 Hong Kong dollars; Heartlinks Medical-B (02160) fell by 5.62%, to 0.84 Hong Kong dollars.
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
Is MicroPort NeuroScientific Corporation's (HKG:2172) Latest Stock Performance A Reflection Of Its Financial Health?
No Data
No Data